FDA Adverse Event Injury Summary report: N

DURALENS

MDR report key: 5632702 · Received May 4, 2016

Report

Report Number
2648035-2016-00697
Event Type
Injury
Date Received
May 4, 2016
Date of Event
April 8, 2016
Report Date
September 7, 2016
Manufacturer
ABBOTT MEDICAL OPTICS
Product Code
HQL
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(6). (B)(4). PMA#: P820049. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 1

DEVICE EVALUATION: THE CUSTOMER DISPOSED OF THE LENS, THEREFORE VISUAL INSPECTION WAS NOT PERFORMED. MANUFACTURING RECORD REVIEW: A MANUFACTURING PROCESS RECORD EVALUATION COULD NOT BE PERFORMED SINCE SERIAL NUMBER OF THE DEVICE IS UNKNOWN/NOT PROVIDED. LABELING REVIEW: THE DIRECTIONS FOR USE (DFU) WAS REVIEWED AND ADEQUATELY PROVIDES INSTRUCTIONS, PRECAUTIONS, AND WARNINGS FOR THE PROPER USE AND HANDLING OF THE INTRAOCULAR LENSES. BASED ON THE INFORMATION PROVIDED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT AN INTRAOCULAR LENS, MODEL DURALENS PS65ATB, WAS EXPLANTED FROM AN EYE OF A FEMALE PATIENT BECAUSE THE LENS DISLOCATED (LENS SINKING TOWARDS THE INFERIOR THROUGH ZONULOLYSIS) WHICH CAUSED DETERIORATION OF HER EYESIGHT. A VITRECTOMY AND AN INCISION ENLARGEMENT (5.5MM CORNEO-SCLERAL ACCESS) WERE PERFORMED AND SUTURES WERE USED. THE SURGEON ALSO REPORTED THE VISUAL ACUITY PRE AND POST-OP. VISUAL ACUITY PRE-OPERATIVE: FZ (MIT +18DPT SPH). VISUAL ACUITY POST-OPERATIVE: 1/35 MV (SC) 2. POSTOPERATIVE DAY. THE PATIENT WAS SATISFIED WITH HER OUTCOME. THE LENS WAS DISPOSED AND WILL NOT BE SENT BACK TO THE MANUFACTURER. NO FURTHER INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
285722 DURALENS MONOFOCAL IOLS HQL ABBOTT MEDICAL OPTICS PS65ATB

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention